Proteasome function and pathological proteins in the pathogenesis of Parkinson's disease.
Nomoto
Masahiro
M
Nagai
Masahiro
M
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D016631:Lewy Bodies / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D009498:Neurotoxins / Q000494:pharmacology*; D016627:Oxidopamine / Q000494:pharmacology*; D010300:Parkinson Disease / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D061988:Proteasome Inhibitors; D020011:Protective Agents / Q000378:metabolism*; D051381:Rats; D013378:Substantia Nigra / Q000473:pathology; D044767:Ubiquitin-Protein Ligases / Q000235:genetics
D009498:Neurotoxins; D061988:Proteasome Inhibitors; D020011:Protective Agents; D016627:Oxidopamine; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D046988:Proteasome Endopeptidase Complex; D004298:Dopamine